Introduction
Mycoplasmas are recognised primarily as extracellular parasites or pathogens of mucosal surfaces, although recent evidence suggests that certain species may invade host
The role of mycoplasmas in disease is also being reassessed in the light of recent findings linking them with other infectious agents, including HIV,l? 2,5-9 meningococci'o. l1 and chlamydiae. 12* l 3 Phagocytic cells, such as macrophages and polymorphonuclear leucocytes (PMNL), comprise the first line of defence against mycoplasmas invading the lung and genitourinary tract.14 Cells of the macrophagemonocyte lineage patrol the respiratory and genitourinary mucosae, accumulating at sites of mycoplasma infe~ti0n.l~ Not only do they carry out effector functions such as receptor-mediated phagocytosis,15~ l6 but they are also important accessory cells of the immune system involved in antigen presentation and the production of cytokines." After an inflammatory stimulus, PMNL (together with peripheral blood monocytes) are also recruited to the area by chemot a x P and large numbers amass in respiratory, synovial and cartilaginous tissues infected with m y c o p l a s m a~.~~~~~ Thus, at the onset of infection, these two cell types are the main mediators of immunity to mycoplasmas; indeed, the outcome of this interaction may determine the subsequent progression of disease.
Over the past 25 years, many of the reports concerning the interaction of mycoplasmas with phagocytes have appeared contradictory, and the mechanisms by which pathogenic mycoplasmas circumvent innate immune responses and go on to establish disease remain poorly understood. In this review, we summarise current knowledge concerning the phagocytosis of mycoplasmas, emphasising recent advances and highlighting areas where knowledge is incomplete, in an attempt to clarify the way forward for future studies. More comprehensive reviews detailing early studies can be found e l s e~h e r e . '~*~' *~~ Received 3 1 March 1994; revised version accepted 1 March 1995.
* Correspondence to be addressed to Dr. Richards.
Interaction between phagocytes and mycoplasmas in vivo
Innate responses to rnycoplasrna infection Many reports describe the interaction of macrophages or PMNL, or both, with mycoplasmas in t~i u 0 .~~-~~ Much of the work has centred on the effects of Mycoplasma pulmonis, a mouse pathogen, on the cellular responses of mice and rats. In the early 1970s, Cassell et a1.18*22 studied the clearance of M . pulmonis from the lower respiratory tract of Fischer rats and CD-1 strain mice. They found that rats were able to clear this mycoplasma from the lung relatively efficiently, with only limited infiltration of PMNL, and deduced that the organisms were taken up rapidly by alveolar macrophages. Mice, on the other hand, cleared mycoplasmas much more slowly and no association between mycoplasma antigen and macrophages was observed. Moreover, the accumulation of PMNL in the bronchi of infected mice was massive and much of the tissue destruction observed was attributed to PMNL hydrolytic activity." Lindsey and Cassellfs have also used immunofluorescence techniques to show the association of M . pulmonis antigen with PMNL in the alveoli of infected mice. Similar prominent alveolar infiltrations of macrophages and PMNL have been observed in mice injected with live, killed or membrane preparations of M . pulmonis, suggesting that mycoplasma antigen alone may be sufficient to attract phagocytes to foci of infection and to stimulate inflammatory responses.22* 3o Recently, Ross et al." have demonstrated that M . puhonis membrane preparations possess a potent chemoattractant activity for peritoneal and alveolar macrophages from fresh rat serum. This is corroborated by Meier et al.,33 who showed increased PMNL aggregation and activation (as measured by respiratory burst activity) in polyarthritic joint fluid from M . arthritidis-infected SPF-Lewis rats, and K o m a t s~,~~ who showed degranulation and specific chemotaxis of eosinophils towards M . pneurnoniae in the lungs of guinea-pigs. In another study, Taylor and Taylor-R~binson~~ observed increased proliferation and dissemination of M . pulmonis and M . pneumoniae in T cell-depleted hamsters and mice, but a decreased severity of disease (as measured by lesion score) when compared with control animals. This was attributed to the reduced accumulation of macrophages and PMNL, which were less activated and showed a reduced capacity to kill mycoplasmas and to induce inflammatory responses.
Many mycoplasma syndromes are characterised by the persistence of antigen in the lung parenchyma before the onset of antibody production, despite the presence of phagocytes. For example, M . bovis antigen has been shown to persist in the lung parenchyma of gnotobiotic calves for at least 4 weeks after infection," and M . pulmonis strains have been shown to survive in the respiratory tract of mice, despite the accumulation of peritoneal macrophages.'6. 27 More recently, Trichopoulos and c o l l e a g~e s~~~ 42 have investigated the effect of M . arthritidis on the phagocytic activity of macrophages of rats and mice. By studying the kinetics of colloidal carbon clearance in the lungs, they have shown that phagocytic activity is significantly depressed 12 h post-infection, returns to normal at 24 h, then increases significantly by 7 days, and subsequently returns to control levels by the end of the fourth week.42 They suggest that the early depressive effect on phagocytic activity may be related to superantigen activity, with the production of suppressive cytokines, such as macrophage-de-activating factor. The later expansion of the macrophage population might result from the stimulation of autoreactive clones of T and B lymphocytes. Presumably, increased macrophage activity may also be a factor in the development of the chronic arthritis found in mycoplasma-infected mice.
Factors that aflect innate responses
The killing and clearance of M . pulmonis from the respiratory tract, in the absence of specific antibody, depend on the strain of rny~oplasma,~~ mousez8 or rat3' studied ; thus, differences in disease severity from host to host may relate to the effectiveness of nonspecific phagocytic mechanisms in eliminating particular mycoplasma Recently Lai et ~1 .~~ studied the genetic control of resistance to M . pulmonis infection in mice, demonstrating that macrophages harvested from infected H-2b (C57BL/6) mice are much more effective at killing mycoplasmas than macrophages from infected CT (T2) mice. Activation of macrophage bactericidal function may help to explain genetic variation in resistance to M . pulmonis infection.
Different types of phagocytic cell also exhibit varying mycoplasmacidal activity. 
What do in-vivo studies tell us?
Clearly the outcome of the initial mycoplasmaphagocyte interaction plays an important role in determining the progression of infection and the severity of disease. Several factors appear to determine the capacity of a host to eliminate mycoplasmas by phagocytosis. First, phagocyte activation, induced by mycoplasma either directly or via cytokine production, is important in determining mycoplasmacidal activity. Second, the efficiency of phagocytosis varies with both the strain of mycoplasma and the individual host. Third, the nature and origin of a phagocyte influence its capacity to engulf and destroy mycoplasmas, probably as a result of differences in surface receptors or bactericidal mechanisms. Finally, environmental factors may modulate the innate immune system resulting in impaired phagocytic responses.
Interaction between phagocytes and mycoplasmas in vitro
The importance of opsonisation Three basic types of interaction between phagocytes and mycoplasmas have been studied in vitro; phagocytosis of unopsonised mycoplasmas, phagocytosis of mycoplasmas exposed to non-specific serum opsonins (e.g., complement), and phagocytosis of mycoplasmas exposed to specific serum opsonins (e.g., IgG or IgA). Most mycoplasmas resist phagocytosis in the absence of opsonins ( resistance of unopsonised mycoplasmas to phagobactericidal activity,", 50-54 whereas studies with cytosis is not particularly significant in pathogenesis electronmicroscopy (EM), chemiluminescence (CL) and as many species of bacteria avoid phagocytosis in 14C0, production demonstrate increased phagocytosis the absence of opsonins, and unopsonised cells are and respiratory burst activity when mycoplasmas essentially " artificial " and would rarely if ever be are treated with non-specific ~p~~n i n~.~~~~ This encountered by phagocytes in vivo. may reflect phagocytosis of mycoplasmas which The lack of published data on the interaction of retain their viability. Surprisingly, little work has been non-specifically opsonised mycoplasmas with phagoperformed on the phagocytosis of non-specifically cytes is surprising as non-immune host defences opsonised cells of M . pneumoniae, the main mycoare a key stage in resistance to infection. Non-specific plasma pathogen in man (table) . For pathogens such opsonisation involves the deposition of complement as M . hominis51. 52, 59 and M . fermentans strain incogbreakdown products (C3b, C3bi, C3dg and C4b) on n i t~s ,~' data indicate survival following phagocytosis the mycoplasma cell surface, but other opsonins, such in the presence of non-specific opsonins; however, as C-reactive protein, fibronectin, a2-macroglobulin, such mycoplasmas may be exceptional.60 lipoprotein surfactants, tuftsin and non-specific serum Most in-vitro studies have concentrated on specificproteases may also be involved. For many mycoplasma ally opsonised mycoplasmas (table) . Opsonisation species, viable count data suggest that non-specific with specific antibody, either with or without compleopsonisation has little beneficial effect on phagocyte ment is followed usually by rapid phagocytosis and intracellular killing,'6*2'q 50,51*61-65 although not always.50, 52-54 The increased efficiency of phagocytic uptake and killing results from the specific recognition of the Fc portion of mycoplasma-bound IgG or IgA by receptors on the phagocyte surface. Provided that it is of the right idiotype-isotype, antibody can act as an effective opsonin and agglutinin as well as directly neutralising mycoplasmas. Those cases in which antibodies have been ineffective in promoting phagocytosis probably reflect the fact that they were inappropriate or non-opsonic.
In-ziitro methods for studying the mycoplasmaphagoc-vte interaction
Several approaches have been adopted in the search for a reliable in-vitro assay to assess the rate and extent of mycoplasma ingestion and killing by phagocytes, these include phase-contrast electronmicroscopy ( E M ) 5 Techniques such as microscopy, autoradiography, uptake of radiolabelled organisms, immunofluorescence and ELISA assess the topological relationship between mycoplasmas and phagocytes. Others, such as inhibition of 3H-uridine uptake, [f4C]-glucose breakdown, spectrophotometric measurement of enzyme activity and luminol-dependent CL, analyse the metabolic response of phagocytes to mycoplasmas. Phagocyte viability can be measured by trypan blue exclusion assays, whereas viable counts determine extracellular and intracellular survival of mycoplasma.
Technical dificulties
In-vitro studies of the phagocytosis of mycoplasmas are hampered by factors such as bacterial aggreg a t i~n ,~~?
75 the tendency of mycoplasmas to adhere spontaneously to phagocytes,61 the lack of distinguishing morphological or staining properties for mycoplasmas,61 the difficulty in differentiation of cell-adherent and ingested organisms,5o mycoplasma susceptibility to lysis61 and discrepancies between bacterial cells grown in vitro or in uiuo. 26 Ultrastructural studies (e.g., autoradiography and EM) reveal the intracellular or extracellular location of mycoplasmas. The presence of intact organisms in phagolysosomes does not, however, confirm their viability. A major problem in EM experiments is the difficulty of interpreting electronmicrographs because of the similarity between ingested mycoplasmas and PMNL intracellular organelles. Gold-antibody labelling helps to resolve this; Lo et al.sO .sl successfully demonstrated M . .fermentans strain incognitus in diseased tissues by immunochemical staining and EM.
CL and 14C02 production studies allow measurement of the phagocyte respiratory burst elicited by mycoplasmas, but this is not necessarily an indication that effective phagocytosis and intracellular killing has occurred. Both 14C02 production from glucose-1 -[ 14C] and luminol-dependent CL emission indicate that M . hominis elicits a sizeable respiratory burst from PMNLs yet viable count studies show killing is relatively Viable count studies are potentially of great value as they are the only direct means of measuring the mycoplasmacidal activity of phagocytes. Viable mycoplasma counts before and after low-speed centrifugation of the phagocyte-mycoplasma suspension enable the number of mycoplasmas associated with the phagocyte to be ascertained but do not differentiate between adherent and intracellular mycoplasmas. Parkinson and Carters5 claim that viability studies are unsuitable for assessing the attachment and ingestion of mycoplasmas by phagocytes because of mycoplasma aggregation or disaggregation, transient attachment to the phagocyte and leucocytic sedimentation during the assay.
To count live, intracellular mycoplasmas, phagocytes must be lysed by a technique that does not affect mycoplasma viability. Ice-cold distilled water" and gentle ~o n i c a t i o n~~ have both been used successfully ; sonication has the added benefit of dispersing mycoplasma aggregates, a source of error in viablecount assays.82
Can in-uitro assays be related to in-vivo immune responses ?
The applicability of in-vitro assays of phagocytosis in in-vivo cellular immune responses has been q~estioned.'~. 26 Discrepancies in phagocytosis of invitro and in-vivo cultured mycoplasmas have been 75 Standardisation of the mycoplasma culture is fundamental to attaining reproducible results. Culture age affects the outcome of the interaction with the phagocytic cell," probably as a result of changes in mycoplasma affinity for PMNL binding sites and variations in production of metabolites toxic to PMNL during their life cycle. For example, attachment of encapsulated mycoplasmas to phagocytes is likely to vary with capsular size, which depends upon culture age83.84 and growth rate.85 Qualitative or quantitative changes may occur also in the expression of mycoplasma surface antigens in uiuo. Alternatively, host material or non-opsonic antibody may become bound to mycoplasmas and subsequently inhibit the attachment of opsonic antibody or c~m p l e m e n t .~~ Howard and Taylor26 demonstrated that in-vitro phagocytosis studies could not differentiate avirulent and virulent mycoplasma strains, as defined in vitlo.
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This probably reflects the dependence of virulence on a variety of factors, e.g., attachment, antibiotic resistance, production of toxic metabolites etc., rather than on one single determinant.86 Krausse et al.50378 showed that poor stimulation of PMNL CL was associated with increased virulence of clinical isolates of U. ureulyticum and a reference strain of M . pneunzoniue. However, they could not correlate PMNL CL stimulation with virulence for M . homini~.~'
Studies of the phagocytosis of mycoplasmas attached to host cells rather than in suspension may resemble more closely the in-vivo relationship between phagocytes and mycoplasma.21 For other bacteria, CL responses of PMNL depend on whether organisms are adherent to glass or are in su~pension.'~ A further problem of in-vitro studies is that PMNL from peripheral blood are not representative of the highly activated PMNL that marginate and migrate through tissues to foci of infection. 88 The method of opsonisation of mycoplasmas may affect the outcome of phagocyt~sis.~~ If mycoplasmas are treated with serum after attaching to phagocytes, some cells may be inaccessible to o p~o n i n s .~~ However, serum treatment before mixing with phagocytes results in aggregation, which affects attachment, ingestion and enumeration of mycoplasmas. Reports on other bacteria even suggest that pre-opsonisation may increase resistance to phagocyto~is.'~ Variations in specific antibody titres and complement levels in serum may affect reproducibility. Contradictory data on the capacity of specific antisera to opsonise mycoplasmas effectively may have resulted from the use of nonhomologous sera and cells,27,53,54,61,62,71. 75 which can lead to erroneous conclusions about the role of cellular immune mechanisms in the natural host. Discrepancies between the opsonising potential of sera from different species may lie in the recognition of different mycoplasma antigens by the respective host immune systems. For example, antibody raised in different hosts may recognise different epitopes of the same M . pneumoniae P 1 adhesin.86 Specific immunoglobulin raised against different epitopes of mycoplasma antigens may also have varying opsonic capacity, and nonhomologous anti-mycoplasmal immunoglobulins may bind less efficiently to phagocyte Fc receptors due to differences in IgG sub-class distribution. 22, 75 Other methodological factors that affect the reproducibility of in-vitro assays include presence of medium c o m p~n e n t s ,~~,~~, 64* 75 variation (or total disregard) in phagocyte-mycoplasma ratios and cell concentrations,51+ 5 7 7 5 8 * 7 7 * incubation times of reaction 
Mycoplasma and phagocyte function (figure)

At tachmen t
Mycoplasmas attach to the surface membranes of competent phagocytes and often appear to proliferJones and co-workers66-6i found that M . pulmonis multiplied after attachment to the plasma membrane of peritoneal macrophages. Mycoplasmas may withdraw nutrients or gain protection from the action of complement and other serum components by this close association. Failure of IgG to enhance phagocytosis of M . pulmonis has been attributed to the inaccessibility of mycoplasmas within large accumulations of PMNL exudate, and to the concealment of mycoplasmas in the cytoplasmic processes and microvilli of infected cell^.^^.^^ The ability of certain mycoplasmas to bind host immunoglobulins non-immunologically through the expression of receptors for the Fc m~i e t y~l .~~ might also impair phagocytosis. EM shows an intimate association between the plasma membrane of the mycoplasma and that of the phagocyte,66 with a gap of only c'. 5-10 nm between the juxtapositioned membrane^.^^ Radiolabelling, flow cytometry-immunofluorescence and ELISA studies have provided a wealth of information concerning the ability of mycoplasma cells or antigen to bind the surfaces of both professional and non-professional p h a g o~y t e s .~"~~. 6 3 * 6 6 -i 2 Unfortunately, relatively little is understood of the mechanisms of attachment or the mycoplasma surface moieties that determine the outcome of this interaction.
Hydrophobicity is important in determining the outcome of phagocyto~is;~~ bacteria of high hydrophobicity tend to be engulfed more rapidly than those of low hydrophobicity. This phenomenon may be of particular importance to Mycoplasma spp. as their membranes contain large amounts of cholesterol, a highly hydrophobic Furthermore, cholesterol is abundant in bronchial secretionsg6 and is bound avidly by mycoplasmas;97 the capacity of a mycoplasma to assimilate cholesterol from its environment may thus affect interaction with p hagoc ytes.
Adherence of mycoplasmas to the cell surface probably involves lipogly~ans,~' which have been found in all species of Acholeplasma, Anaeroplasma and Spiroplasma studied, and in certain species of Mycoplasma. Lipoglycans exhibit both mitogenic and endotoxic properties, and they are thought to be similar in function to bacterial lipopolysaccharides. 98 At present, PMNL priming by lipoglycans has not been demonstrated ; however, mycoplasma-derived high mol. wt material (MDHM) from M . fermentans has been shown to activate murine macrophages;99 and MDHM, M . arginini TUH-14 membrane lipoproteins, as well as M . pneumoniae and M . pulmonis membranes are known to induce proinflammatory cytokines (i.e., TNF-a, IL-lp, IL-6 and IFN-y);10@107 thus, it seems likely that priming of PMNL or macrophages, or both, does take place. Studies with trypsin suggest the presence of an antiphagocytic surface protein on M . p~l r n o n i s .~~*~~ Following treatment with trypsin (100 pg/ml) the organism was more susceptible to phagocytosis by murine macrophages when observed under phase contrast microscopyG7* ''' or by scanning EM.69
Many mycoplasmas possess a capsule, as determined by ruthenium red staining or EM,114 and several reports suggest their importance in resistance to phagocytosis. Capsules reduce mycoplasma cell surface hydrophobicity, increasing resistance to phagocytosis. Recent studies have demonstrated that bovine lung fibroblasts induce proliferation of the galactan that encapsulates M . d i~p a r ; "~~'~~ this results in inhibition of the bactericidal and secretory functions of bovine alveolar macro phage^."^ Both capsulate organisms and purified capsule preparations suppress tumour necrosis factor a (TNF-cc) production, IL-1 production and glucose consumption by macrophages.l15
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The M . mycoides subsp. mycoides galactan capsule may also stimulate TNF-a, as large colony strains of this species induce TNF-a production in infected goats.115 Non-capsulate M . mycoides cells are more susceptible to non-specific ~psonisation~' probably as a result of decreased complement deposition. However, the capacity of capsulate M . mycoides strains to impair binding of opsonins to the cell surface does not appear to be shared by many other Mycoplasma species. Most mycoplasmas both bind antibody rapidly and activate complement by either the alternative56, 117,118 or the c l a s~i c a l~~~-~'~ pathways, as well as interacting with the C 1 component
P M N L membrane damage
M ycoplasma-medi a t ed damage to the p hag oc y te membrane may occur in several ways. Proteases associated with the mycoplasma rnembranel2' may damage phagocyte membrane integrity. The action of mycoplasma lipases or phospholipase~~~~, 131 on the cell surface may reduce phagocytic function either by generating lipid hydrolysis produ~ts,~' such as sphingosines (potent inhibitors of NADPH oxidase a~t i v i t y l~~) , or by altering membrane one of several factors important in the activation of the PMNL respiratory Mycoplasma oxygen radical production, by damaging the phagocyte membrane, may act as a pathogenicity factor. 134-138 Generation of these oxygen metabolites in close proximity to the PMNL surface may be important in allowing oxidation of PMNL membrane lipid components, 136 thereby affecting membrane fluidity and resulting in the formation of cytotoxic metabolites, such as rna10nyldialdehyde.l~~ Membrane lipid peroxidation via arachidonic acid is also the first stage in a whole spectrum of PMNL metabolic pathways which result in the production of leukotrienes and prostaglandins, two important groups of cytokines involved in inflammatory and cellular immune responses. Mycoplasma radical production may disrupt these and other metabolic pathways, such as the glutathione redox
13'
glutathione synthesis is coupled with respiratory burst activity in PMNL140 and glutathione depletion as a result of mycoplasma oxidative attack might affect PMNL bactericidal capacity. Mycoplasma oxygen radical generation may result in premature inactivation of the PMNL NADPH oxidase, which is sensitive to oxidation by superoxide ion (O2-).l4l Phorbol mystrate acetate (PMA) by-passes receptormediated transmembrane signalling, acting directly on protein kinase C; the inhibition of PMA-induced CL by M . bovis implies that interference with NADPH oxidase activation must occur at the level of protein kinase C activation or later in the p a t h~a y .~' M . fermentans strain incognitus has been shown to damage PMNL (and lymphocyte) membranes, as measured by the trypan blue method. 74 However, in this case, damage to the phagocyte membrane is probably not attributable to autonomous production of oxygen radical, as M . fermentans strain incognitus induces only a relatively weak CL response from PMNL. In contrast, M . fermentans PG18 and M . felis elicit substantial PMNL CL responses, but only mildly affect PMNL membrane integrity.
Intracelluiar survival
Evidence for the survival of mycoplasmas within phagocytes is contradictory; this may reflect the fact that survival depends on the mechanisms by which m ycoplasmas are phagocy tosed. identified M . fermentans strain incognitus in various cell and tissue types, including peripheral blood monocytes, by DNA hybridisation. The mechanism of entry to the PMNL cytoplasm is unknown, but may involve complement receptors ; cellular uptake via CR3 avoids the triggering of some PMNL microbicidal mechanisms and is a strategy employed by a number of intracellular ~ath0gens.l'~ If mycoplasmas can exist intracellularly within phagocytes, how do they escape phagocyte bactericidal mechanisms? Resistance of mycoplasmas to oxygen radicals and chloramines generated by phagocytes during the respiratory burst is hard to explain, as these organisms are sensitive to the same oxygen radicals generated in cell-free 145 The close proximity of mycoplasmas to the phagocyte membrane may be in some way p r~t e c t i v e .~~ Serum is an effective scavenger of H,O, and binding of serum components, such as catalase, by mycoplasmasg7 might account for the resistance of serum-treated cells to phagocyte oxidative attack. Mycoplasmas themselves produce substantial amounts of active oxygen radicals and may thus possess efficient enzymic processes for their inactivation. However, reports of catalase and superoxide dismutase (SOD) activity in mycoplasmas are 137, 146 and it seems unlikely they have sufficiently high levels of such enzymes to avoid damage by phagocyte oxygen radicals. Furthermore, levels of SOD and catalase production do not correlate with virulence or resistance to phagocytic killing for other bacteria. 147 Alternative mechanisms by which mycoplasmas may avoid phagocytic killing include inhibition of myeloperoxidase, and detoxification of oxidants via reducing agents secreted or exposed on the mycoplasma surface,
Resistance of mycoplasmas to non-oxidative microbicidal mechanisms of phagocytes is poorly understood. M . pulmonis elicits the release of hydrolytic enzymes from macrophages, suggesting that mycoplasmas are exposed to attack by serine proteases and defen~ins.~' Erb and Bredt76 proposed that the high lipid content of mycoplasma membranes might protect against phagocyte intraphagosomal components but found no evidence for this. Lysosomal enzymes, such as lysozyme, would have little effect on mycoplasmas as they lack a cell envelope.5o On the other hand, the lack of a cell wall predisposes mycoplasmas to direct attack by other lysosomal enzymes. The sensitivity of mycoplasmas to PMNL lysates and intracellular killing mechanisms of PMNL in oitro suggests that inherent resistance to nonoxidative killing is unlikely.52* 14*, 14' Ammonia may interfere with phagosome-lysosome fusion in PMNL'50v151 and its production by mycoplasmas has been proposed as a virulence facAmmonia is formed by the hydrolysis of urea by ureaplasmas, and of L-arginine by many Mycopfasma spp. Furthermore, as these reactions are major or sole sources of energy generation in the species concerned, large quantities of substrate will be consumed during growth. Reduced availability of Larginine can affect the metabolism of mammalian cells and, in particular, the bio~ynthesisl~~ of nitric oxide. Macrophage-derived nitric oxide is involved in tumour cell c y t o s t a~i s l~~ and the killing or inhibition of growth of bacteria.156 Thus, arginine-utilising mycoplasmas (e.g., M . hominis and M . fermentans) may disrupt p hagoc y te bactericidal capacity .
tor.152, 153
Conclusions
A number of conclusions can be drawn from the current extent of our knowledge of the phagocytemycoplasma interaction and its implications in the wider context of mycoplasma pathogenicity.
First, the presence of opsonins is important in determining the fate of the mycoplasma following interaction with the phagocyte. Opsonisation by specific antibody results almost invariably in the rapid phagocytosis and destruction of the mycoplasma. Further work is required to determine if this is a result of antibody neutralisation of mycoplasma antiphagocytic mechanisms, increased aggregation of mycoplasmas, increased efficiency of Fc receptormediated phagocytosis, or a combination of factors. The outcome of complement-mediated phagocytosis is less clear; recent studies suggest that non-specifically opsonised cells are phagocytosed, but some may escape bactericidal mechanisms. The state of priming or activation of the phagocytic cell is likely to be important in determining the success of non-specific phagocytosis of mycoplasmas. Recent evidence suggests that the NADPH oxidase of activated cells produces enhanced amounts of H,O, and superoxide
In addition, the increased expression of membrane receptors and the enhanced efficiency of degradation results in the more effective bacterial killing observed with activated phagocytes. The importance of priming on phagocyte function emphasises the need to study the effect of Mycopfasma spp. on host cytokine p r~d u c t i o n ,~~~"~~ and in turn the effects of these cytokines on phagocyte f~n c t i o n .~'~~ 116 Second, the type and origin of the phagocyte encountered by a mycoplasma is important in determining its subsequent survival. Both PMNL and mononuclear phagocytes can phagocytose mycoplasmas effectively in the presence of antibody, providing it is of the right idiotype-isotype. However, they may differ in their ability to kill mycoplasmas in the absence of antibody. Furthermore, NK cells, rather than PMNL or macrophages, have been reported to be responsible for mycoplasmacidal activity in the respiratory tract of mice.31v46-3i Future studies should investigate the role of different cell types in resistance to mycoplasma infection in the nonimmune host.
Finally, the assumption that mycoplasmas are phagocytosed in the host only after an antibody response must be re-evaluated. Many investigators have disregarded the role of complement or other nonspecific opsonins. Mycoplasma infection results in a massive increase in localised concentrations of complement components in bronchial secretions. 15' Increased vascular permeability during inflammation would be expected to elevate levels of complement further. In addition, a distinct functionally active leucocyte complement system exists on the surface of macrophages and lymphocytes,g0* 160 and macrophages co-operate with PMNL in phagocytosis in vitro by providing opsonins."' This evidence suggests strongly that mycoplasmas are exposed to complement, even at extracellular mucosal sites, in the non-immune host. Therefore, the use of unopsonised cells in in-vitro studies to represent the interaction of mycoplasmas with phagocytes in the non-immune host is inappropria te.
Recent studies highlight the susceptibility of patients with antibody deficiency to mycoplasma infection.51. 162 The emergence of mycoplasmas as opportunists in HIV infection^,^.^ where antibody levels are also depleted, is of particular note. The capacity of mycoplasmas to impair the phagocytosis of other bacteria in vitro emphasises their possible role as copathogens with chlamydiae, meningococci and HIV.
The ability of some pathogenic mycoplasmas to avoid killing in the presence of complement and PMNL is important to understanding the pathogenesis of mycoplasma infections. Enhanced PMNL oxidative activity in the presence of complement-opsonised mycoplasmas may result in alveolar damage'63 and may account for the necrotic nature of lesions associated with mycoplasma infection.'l Webster et ~1 .~' even go so far as to suggest that phagocytosis of pathogenic mycoplasmas in the absence of antibody may be an important factor in the dissemination of mycoplasma disease.
The interaction between mycoplasmas, phagocytes and complement components, and their influence on recovery from mycoplasma disease are extremely complex. Further study of the mechanisms involved in the mycoplasma-phagocyte interaction, and of the genetic basis for phagocytic competence against these bacteria, will enable us to understand more fully the
